SEC Filing Alert: Form 15-15D Filed by Filer SPECIFICITY, INC. (0001840102)
In a recent SEC filing, Specificity, Inc. (CIK: 0001840102) submitted a Form 15-15D, indicating the termination of its registration under the Securities Exchange Act of 1934. This move signifies that the company will no longer be required to file certain reports with the SEC, reducing administrative burden and costs associated with regulatory compliance. Specificity, Inc.’s decision to deregister may suggest a shift in its strategic focus or a desire to operate with more flexibility outside the public market scrutiny.
Specificity, Inc. is a biotechnology company that specializes in developing innovative diagnostic tools for personalized medicine applications. By leveraging cutting-edge technology, the company aims to revolutionize healthcare by providing tailored solutions for individual patients. For more information about Specificity, Inc., please visit their official website: Specificity, Inc..
Form 15-15D is a filing with the SEC used by companies to voluntarily deregister their securities and suspend reporting obligations. This form is typically submitted by companies that no longer have securities listed on a national exchange or those with fewer than 300 shareholders of record. By filing Form 15-15D, Specificity, Inc. is signaling its intention to cease public reporting and registration, streamlining its operations and potentially exploring alternative avenues for growth and development.
Read More:
SEC Form 15-15D Filed by Specificity, Inc. for Regulatory Compliance
